In the first half of 2025, Hiscore Co., Ltd. actively participated in industry events. Through a series of exhibition activities, it fully demonstrated the company's innovative strength and cutting-edge technologies, which aroused a warm response in the industry.

In April, Hiscore made an appearance at the 2025 National Academic Conference of the Chinese Society for Cell Biology · Zhuhai. The conference was grandly held at the Zhuhai International Convention and Exhibition Center, gathering top domestic scientific research teams, experts, scholars and industry elites.

At the exhibition, Hiscore focused on displaying its independently developed long-term and high-throughput live cell imaging system. Its excellent performance and innovative technical concepts attracted the attention of many visitors.

On-site staff enthusiastically explained the unique advantages of the product to the audience, such as long-term stable imaging and high-resolution capture of cell dynamic changes, which aroused strong interest from many potential customers. Many professionals conducted in-depth exchanges and discussions on the application scenarios and technical details of the product on the spot.

In May, Hiscore lost no time in participating in the first International Organoid conference, ISFO2025.This international event, hosted by Fudan University, focused on the latest research achievements and development trends in the field of organoids, attracting experts, scholars and enterprise representatives from many countries and regions around the world. During the conference, the staff gave detailed explanations to the participants on how the system facilitates research processes such as organoid cultivation observation and growth monitoring, and shared relevant successful cases.

At the 4th ISO Stem Cell Therapy and Organoid Deep Focus Forum held in June, Hiscore's long-term, high-throughput live cell imaging system once again won high praise from participants for its outstanding performance in stem cell research and organoid applications. This forum not only helped Hiscore further expand its influence in the fields of stem cell therapy and organoids but also enabled the company to gain more cutting-edge industry information and market demands, providing strong reference for its subsequent technological R&D and product optimization.

In the first half of the year, Hiscore's EOS1 cell imaging system made its debut at the London Organoid Congress. As an innovative product that embodies the company's core technologies, this marked a significant breakthrough for the company's products on the international exhibition stage.

The several exhibitions in the first half of 2025 have served as important platforms for Hiscore to showcase itself, exchange ideas, learn from others, and expand cooperation. Looking ahead, Hiscore will continue to uphold the spirit of innovation, constantly enhance its technical strength and product quality, and move forward steadily on the path of biotechnology. We look forward to meeting you again at more industry events and contributing together to the development of the biotechnology field.